Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 2 (ICAC-30)
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms MUPPITS-2
- 01 Nov 2017 Status changed from not yet recruiting to recruiting.
- 10 Oct 2017 Planned initiation date changed from 1 Sep 2017 to 1 Oct 2017.
- 27 Sep 2017 New trial record